Centaurus Financial Inc. Invests $3.74 Million in Welltower Inc. $WELL

Centaurus Financial Inc. purchased a new stake in Welltower Inc. (NYSE:WELL) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 16,460 shares of the real estate investment trust’s stock, valued at approximately $3,736,000.

Several other hedge funds also recently added to or reduced their stakes in WELL. BlackRock Inc. lifted its position in shares of Welltower by 5.5% during the 2nd quarter. BlackRock Inc. now owns 78,049,214 shares of the real estate investment trust’s stock worth $17,714,830,000 after buying an additional 4,045,458 shares during the last quarter. Capital International Investors lifted its position in Welltower by 2.0% in the fourth quarter. Capital International Investors now owns 47,431,769 shares of the real estate investment trust’s stock valued at $8,805,411,000 after acquiring an additional 915,514 shares during the last quarter. State Street Corp boosted its stake in Welltower by 1.2% in the fourth quarter. State Street Corp now owns 41,760,328 shares of the real estate investment trust’s stock valued at $7,751,134,000 after acquiring an additional 506,374 shares in the last quarter. Norges Bank purchased a new position in shares of Welltower during the fourth quarter worth about $5,466,264,000. Finally, Bank of America Corp DE increased its position in shares of Welltower by 6.6% during the first quarter. Bank of America Corp DE now owns 21,750,501 shares of the real estate investment trust’s stock worth $4,300,291,000 after purchasing an additional 1,347,243 shares in the last quarter. 94.80% of the stock is currently owned by hedge funds and other institutional investors.

Welltower Price Performance

Shares of NYSE WELL opened at $239.42 on Friday. The company has a debt-to-equity ratio of 0.37, a current ratio of 3.16 and a quick ratio of 3.16. The stock has a fifty day moving average price of $234.93 and a 200 day moving average price of $217.45. Welltower Inc. has a 1-year low of $163.75 and a 1-year high of $255.20. The company has a market cap of $172.56 billion, a PE ratio of 109.82, a P/E/G ratio of 1.16 and a beta of 0.76.

Welltower (NYSE:WELL) last announced its quarterly earnings data on Monday, July 27th. The real estate investment trust reported $0.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.66 by ($0.05). The firm had revenue of $3.54 billion during the quarter, compared to analyst estimates of $3.40 billion. Welltower had a net margin of 12.15% and a return on equity of 3.56%. The business’s quarterly revenue was up 39.1% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.28 earnings per share. Welltower has set its FY 2026 guidance at 6.360-6.440 EPS. Sell-side analysts forecast that Welltower Inc. will post 6.43 EPS for the current year.

Welltower Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, August 20th. Stockholders of record on Wednesday, August 12th were paid a dividend of $0.85 per share. This represents a $3.40 dividend on an annualized basis and a dividend yield of 1.4%. This is a positive change from Welltower’s previous quarterly dividend of $0.74. The ex-dividend date was Wednesday, August 12th. Welltower’s dividend payout ratio (DPR) is presently 155.96%.

Insider Transactions at Welltower

In other news, Director Andrew Gundlach acquired 5,000 shares of Welltower stock in a transaction that occurred on Tuesday, August 25th. The stock was purchased at an average price of $239.47 per share, for a total transaction of $1,197,350.00. Following the completion of the transaction, the director directly owned 25,000 shares in the company, valued at approximately $5,986,750. This trade represents a 25.00% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.37% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts recently issued reports on WELL shares. Mizuho upped their target price on Welltower from $239.00 to $260.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. Cantor Fitzgerald raised their target price on shares of Welltower from $235.00 to $260.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. UBS Group upped their price target on shares of Welltower from $249.00 to $271.00 and gave the company a “buy” rating in a research report on Wednesday, July 8th. Wall Street Zen raised shares of Welltower from a “sell” rating to a “hold” rating in a research report on Saturday, May 2nd. Finally, KeyCorp upped their target price on shares of Welltower from $240.00 to $275.00 and gave the company an “overweight” rating in a report on Tuesday, August 4th. Fourteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $246.11.

Welltower Profile

Welltower Inc (NYSE: WELL) is a real estate investment trust (REIT) that acquires and manages real estate serving the health care industry. The company specializes in healthcare infrastructure, owning and operating a diversified portfolio of senior housing, post-acute and long-term care communities, and outpatient medical properties. Welltower’s assets are designed to support the delivery of health care services through a combination of leased properties, joint ventures, and other capital arrangements with health care operators and providers.

The company’s property types include assisted living, memory care, independent living and skilled nursing facilities, as well as medical office buildings and other outpatient-care real estate such as ambulatory surgery centers and specialty clinics.